In recognition of our success in active pharmaceutical ingredient (API) process development, Tokuyama was chosen as one of the six finalists for the Excellence in Pharma award in the API Development category as part of the CPhI Pharma Awards 2019.

The CPhI Pharma Awards demand originality and are granted to technologies based on actual production among each of the sectors in the healthcare business. The API Development entry by Tokuyama was nominated by process chemists from original and generic API producers throughout the world as a top-class manufacturing technology that pursues efficiency and economy to the greatest extent possible.

The Excellence in Pharma award recipient will be selected following a final screening. The award ceremony is scheduled to be held on November 5 during CPhI-Worldwide 2019 in Frankfurt, Germany, at which Tokuyama will also be exhibiting.

≪Reference≫
CPhI Pharma Awards 2019 : https://awards.cphi.com/finalists/